MedPath
NMPA Approval

Bevacizumab Injection

国药准字S20210045

November 17, 2021

Drug Information

贝伐珠单抗注射液

普贝希

注射剂

400mg/16mL

生物制品

November 17, 2021

Company Information

Applicant Company

广州高新技术产业开发区科学城开源大道11号A6栋第五层

Manufacturing Company

广州市黄埔区永和经济开发区摇田河大街155号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

贝伐珠单抗注射液 - NMPA 批准文号 | MedPath